Immunotherapy could be beneficial for relapsed acute myeloid leukemia

December 11, 2017

Researchers led by UNC Lineberger’s Joshua Zeidner, MD, presented preliminary results from an ongoing phase II trial of the checkpoint inhibitor pembrolizumab and chemotherapy for relapsed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta.

A few minutes with Regina Jones

November 30, 2017

A desire to give back has led breast cancer survivor Regina Jones to volunteer at the N.C. Cancer Hospital, UNC Lineberger’s clinical home. Jones is a member of the Patient & Family Advisory Council, or PFAC, which is composed of patients, family members, survivors, caregivers and staff who work together to ensure that patients receive the highest level of care.